During the past decade, ZNA Stuivenberg conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 32 clinical trials were completed, i.e. on average, 51.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 24 clinical trials were completed. i.e. 126.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ZNA Stuivenberg" #1 sponsor was "The Lymphoma Academic Research Organisation" with 13 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 9 trials sponsored, "Amgen" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Incyte Corporation" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ZNA Stuivenberg" #1 collaborator was "Swiss Group for Clinical Cancer Research" with 3 trials as a collaborator, "Ziekenhuis Netwerk Antwerpen (ZNA)" with 3 trials as a collaborator, "AZ Sint-Jan AV" with 2 trials as a collaborator, "AZ-VUB" with 2 trials as a collaborator and "AbbVie" with 2 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "ZNA Stuivenberg" are "Multiple Myeloma" (12 trials), "Acute Myeloid Leukemia" (8 trials), "Follicular Lymphoma" (4 trials), "Myelodysplastic Syndromes" (4 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "ZNA Stuivenberg" in a lesser frequency.

Most popular intervention types in "ZNA Stuivenberg" are "Drug" (81 trials), "Other" (8 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (9 trials), "Placebo" (7 trials), "Lenalidomide" (5 trials), "placebo" (5 trials) and "Bendamustine" (4 trials). Other intervention names were less common.

The vast majority of trials in "ZNA Stuivenberg" are 94 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "ZNA Stuivenberg". undefined are not yet recruiting, 14 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in ZNA Stuivenberg, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in ZNA Stuivenberg, 8 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".